Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 48, Issue 1, 2009, Pages

  Müller, Alexandra D ^a   Myer, Landon ^a   Jaspan, Heather ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CHILD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; METHODOLOGY; PATIENT COMPLIANCE; PRESCHOOL CHILD; SOUTH AFRICA; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFANT; PATIENT COMPLIANCE; REVERSE TRANSCRIPTASE INHIBITORS; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 58149332691     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/595553     Document Type: Article

References (0)